Correlation Between Vaccibody and Monopar Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Vaccibody and Monopar Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vaccibody and Monopar Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Vaccibody As and Monopar Therapeutics, you can compare the effects of market volatilities on Vaccibody and Monopar Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vaccibody with a short position of Monopar Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vaccibody and Monopar Therapeutics.

Diversification Opportunities for Vaccibody and Monopar Therapeutics

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Vaccibody and Monopar is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Vaccibody As and Monopar Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Monopar Therapeutics and Vaccibody is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vaccibody As are associated (or correlated) with Monopar Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Monopar Therapeutics has no effect on the direction of Vaccibody i.e., Vaccibody and Monopar Therapeutics go up and down completely randomly.

Pair Corralation between Vaccibody and Monopar Therapeutics

If you would invest  3,352  in Monopar Therapeutics on November 27, 2024 and sell it today you would earn a total of  247.00  from holding Monopar Therapeutics or generate 7.37% return on investment over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy0.0%
ValuesDaily Returns

Vaccibody As  vs.  Monopar Therapeutics

 Performance 
       Timeline  
Vaccibody As 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Vaccibody As has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound fundamental indicators, Vaccibody is not utilizing all of its potentials. The recent stock price tumult, may contribute to shorter-term losses for the shareholders.
Monopar Therapeutics 

Risk-Adjusted Performance

Good

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Monopar Therapeutics are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. Even with relatively weak basic indicators, Monopar Therapeutics reported solid returns over the last few months and may actually be approaching a breakup point.

Vaccibody and Monopar Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Vaccibody and Monopar Therapeutics

The main advantage of trading using opposite Vaccibody and Monopar Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vaccibody position performs unexpectedly, Monopar Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Monopar Therapeutics will offset losses from the drop in Monopar Therapeutics' long position.
The idea behind Vaccibody As and Monopar Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.

Other Complementary Tools

Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites